These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 8909302

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
    Gaspar LE, Winter K, Kocha WI, Coia LR, Herskovic A, Graham M.
    Cancer; 2000 Mar 01; 88(5):988-95. PubMed ID: 10699886
    [Abstract] [Full Text] [Related]

  • 4. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
    Weiner LM, Colarusso P, Goldberg M, Dresler C, Coia LR.
    Semin Oncol; 1997 Dec 01; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
    [Abstract] [Full Text] [Related]

  • 5. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N, Park SD, Lynch T, Wright C, Ancukiewicz M, Wain J, Donahue D, Mathisen D.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):111-22. PubMed ID: 15337546
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus.
    Forastiere AA, Heitmiller RF, Lee DJ, Zahurak M, Abrams R, Kleinberg L, Watkins S, Yeo CJ, Lillemoe KD, Sitzmann JV, Sharfman W.
    Cancer J Sci Am; 1997 Sep 01; 3(3):144-52. PubMed ID: 9161779
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.
    Meluch AA, Hainsworth JD, Gray JR, Thomas M, Whitworth PL, Davis JL, Greco FA.
    Cancer J Sci Am; 1999 Sep 01; 5(2):84-91. PubMed ID: 10198730
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of cisplatin, 5-fluorouracil, and paclitaxel regimen for carcinoma of the esophagus.
    Belani CP, Luketich JD, Landreaneau RJ, Kim R, Ramanathan RK, Day R, Ferson PF, Keenan RJ, Posner M, Seeger J, Lembersky B.
    Semin Oncol; 1997 Dec 01; 24(6 Suppl 19):S19-89-S19-92. PubMed ID: 9427275
    [Abstract] [Full Text] [Related]

  • 11. Neoadjuvant chemotherapy in squamous cell carcinoma of the esophagus using low dose continuous infusion 5-fluorouracil and cisplatin: results of a prospective study.
    Aroori S, Parshad R, Kapoor A, Gupta SD, Kumar A, Chattophadyay TK.
    Indian J Cancer; 2004 Dec 01; 41(1):3-7. PubMed ID: 15105572
    [Abstract] [Full Text] [Related]

  • 12. Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost.
    Brunner TB, Rupp A, Melzner W, Grabenbauer GG, Sauer R.
    Strahlenther Onkol; 2008 Jan 01; 184(1):15-22. PubMed ID: 18188518
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Concurrent chemoradiotherapy with nedaplatin and 5-fluorouracil (5-fu) for locally advanced squamous cell carcinoma of the esophagus].
    Kubo N, Morimoto J, Tanaka H, Ohira M, Noda E, Amano R, Inoue T, Yamada N, Yashiro M, Maeda K, Yamashita Y, Muguruma K, Sawada T, Hirakawa K.
    Gan To Kagaku Ryoho; 2009 Nov 01; 36(12):1997-9. PubMed ID: 20037303
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA.
    Semin Oncol; 1997 Dec 01; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
    [Abstract] [Full Text] [Related]

  • 17. Phase I trial of oxaliplatin in combination with cisplatin, protacted-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinoma.
    Maurel J, Cervantes A, Conill C, Salazar R, Martin-Richard M, Pera M, Manzano H, Chirivella I, Gallego R, Marfa X.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):91-6. PubMed ID: 15850907
    [Abstract] [Full Text] [Related]

  • 18. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.
    Kim DW, Blanke CD, Wu H, Shyr Y, Berlin J, Beauchamp RD, Chakravarthy B.
    Int J Radiat Oncol Biol Phys; 2007 Feb 01; 67(2):397-404. PubMed ID: 17097833
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ten-year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus.
    Bidoli P, Bajetta E, Stani SC, De CD, Santoro A, Valente M, Zucali R, Valagussa P, Ravasi G, Bonadonna G.
    Cancer; 2002 Jan 15; 94(2):352-61. PubMed ID: 11900221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.